Skip to content

Ardent Health Partners ARDT Issuance of vested restricted stock units

Issuance of vested restricted stock units at other companies

ARD
Ardent Health PartnersARDT
-$1.01M+4.4%
UFP Technologies logo
UFP TechnologiesUFPT
-$3.57M+8.8%
Zymeworks logo
ZymeworksZYME
$0
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$0
FTI Consulting logo
FTI ConsultingFCN
-$2.37M+67.2%
DJT
Trump Media & Technology GroupDJT
$0

Other financials

Income statement

See full
Revenue$1.6B+7.0%
Gross profit$1.6B+6.7%
Net income$39.9M-3.7%
EPS (diluted)$0.28-3.4%

Balance sheet

See full
Cash & equivalents$609.7M+23.2%
Total debt$1.2B+1.7%
Total equity$1.3B+13.8%
Total assets$5.3B+7.0%

Cash flow

See full
Operating cash flow-$60.2M-143%
CapEx$28.1M+22.6%
Free cash flow-$88.3M-85.2%

Valuation

See full
Market cap$1.35B-37.7%
Enterprise value$1.91B-31.9%
P/E10×+0.4×
P/S0.2×-0.1×

Profitability

See full
Gross margin97.5%-0.1pp
Net margin2.1%-1.6pp
FCF margin3.4%+1.4pp

Returns & leverage

See full
Return on equity10.7%-9.0pp
Debt / equity0.9×-0.1×
Current ratio2.1×0.0×

Where this comes from

Reported directly by Ardent Health Partners in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures.

The official record: Ardent Health Partners’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardent Health Partners's issuance of vested restricted stock units.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardent Health Partners's issuance of vested restricted stock units?
Ardent Health Partners (ARDT) reported issuance of vested restricted stock units of -$1.01M in Q1 2026.
How has Ardent Health Partners's issuance of vested restricted stock units changed year-over-year?
Ardent Health Partners's issuance of vested restricted stock units increased by 4.4% year-over-year, from -$1.06M to -$1.01M.
What does issuance of vested restricted stock units mean?
The value of common stock issued upon the vesting of restricted stock units (RSUs) granted to employees and directors. This represents a non-cash compensation expense that aligns employee incentives with shareholder interests.